Alimera Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2008
Net Income	-21.42	-21.39	-18.11	-4.37	-5.34	-10.44	Upgrade
Depreciation & Amortization	11.15	8.75	2.71	2.58	2.68	2.64	Upgrade
Share-Based Compensation	2.05	1.44	0.91	1	1.33	2.46	Upgrade
Other Operating Activities	-4.41	-4.31	4.52	-2.43	-0.86	1.19	Upgrade
Operating Cash Flow	-12.62	-14.26	-9.98	-3.22	-2.19	-4.15	Upgrade
Capital Expenditures	-0.27	-0.26	-0.26	-0.62	-0.62	-0.17	Upgrade
Other Investing Activities	-75.27	-75.27	-	-	-	-	Upgrade
Investing Cash Flow	-75.54	-75.53	-0.26	-0.62	-0.62	-0.17	Upgrade
Share Issuance / Repurchase	2.44	2.09	0.1	10.04	0.05	0.9	Upgrade
Debt Issued / Paid	20.4	17.91	-0.4	-0.22	3.85	-0.03	Upgrade
Other Financing Activities	66.63	76.5	-	-	-0.02	-	Upgrade
Financing Cash Flow	89.47	96.5	-0.3	9.82	3.88	0.87	Upgrade
Exchange Rate Effect	-0.08	0.08	-0.71	-0.68	0.71	-0.16	Upgrade
Net Cash Flow	1.23	6.79	-11.24	5.3	1.78	-3.62	Upgrade
Free Cash Flow	-12.89	-14.52	-10.23	-3.85	-2.81	-4.33	Upgrade
Free Cash Flow Margin	-14.29%	-17.98%	-18.90%	-6.51%	-5.54%	-8.02%	Upgrade
Free Cash Flow Per Share	-0.24	-0.57	-1.46	-0.58	-0.55	-0.91	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).